Abstract
The maintenance and assembly of chromatin is critical for the health of all cells. Cells, whether dividing or quiescent, that propagate damaged DNA or maintain chromosomes that are not properly assembled and/or packaged will ultimately succumb to genomic instability and cell death. Chromatin, the building block of the chromosome, is composed of repeated units of 147 basepairs of DNA wrapped around two copies of each of the four core histones, H2A, H2B, H3 and H4. Histones within chromatin serve as templates for a host of posttranslational modifications that facilitate virtually all events that require chromatin or chromosomes. Many studies have focused on the molecular mechanisms mediating and regulating the assembly process. These studies have utilized model systems ranging from yeast to humans. The regulatory processes are tightly linked to the cell cycle and require precise interactions between kinase cascades and the ubiquitintargeting pathway. It appears likely that not only are the series of factors required to assemble chromatin conserved across evolutionary boundaries, but so are the regulatory mechanisms that control these processes. The implications of these findings to research make it clear that lower eukaryotic model systems provide a powerful opportunity to learn valuable lessons about complicated higher eukaryotic molecular pathways. The lessons learned from yeast studies will provide valuable insight into understanding the disease processes that occur in humans as a result of impaired chromatin assembly.
Keywords: chromatin assembly, caf-I, anaphase promoting complex, mitosis, evolutionary conservation
Current Genomics
Title: Chromatin Assembly from Yeast to Man: Conserved Factors and Conserved Molecular Mechanisms
Volume: 6 Issue: 4
Author(s): Troy A.A. Harkness
Affiliation:
Keywords: chromatin assembly, caf-I, anaphase promoting complex, mitosis, evolutionary conservation
Abstract: The maintenance and assembly of chromatin is critical for the health of all cells. Cells, whether dividing or quiescent, that propagate damaged DNA or maintain chromosomes that are not properly assembled and/or packaged will ultimately succumb to genomic instability and cell death. Chromatin, the building block of the chromosome, is composed of repeated units of 147 basepairs of DNA wrapped around two copies of each of the four core histones, H2A, H2B, H3 and H4. Histones within chromatin serve as templates for a host of posttranslational modifications that facilitate virtually all events that require chromatin or chromosomes. Many studies have focused on the molecular mechanisms mediating and regulating the assembly process. These studies have utilized model systems ranging from yeast to humans. The regulatory processes are tightly linked to the cell cycle and require precise interactions between kinase cascades and the ubiquitintargeting pathway. It appears likely that not only are the series of factors required to assemble chromatin conserved across evolutionary boundaries, but so are the regulatory mechanisms that control these processes. The implications of these findings to research make it clear that lower eukaryotic model systems provide a powerful opportunity to learn valuable lessons about complicated higher eukaryotic molecular pathways. The lessons learned from yeast studies will provide valuable insight into understanding the disease processes that occur in humans as a result of impaired chromatin assembly.
Export Options
About this article
Cite this article as:
Harkness A.A. Troy, Chromatin Assembly from Yeast to Man: Conserved Factors and Conserved Molecular Mechanisms, Current Genomics 2005; 6 (4) . https://dx.doi.org/10.2174/1389202054395937
DOI https://dx.doi.org/10.2174/1389202054395937 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cell-Penetrating Peptides: Mechanisms and Applications
Current Pharmaceutical Design New Insights on the Antitumoral Properties of Prodiginines
Current Medicinal Chemistry Aberrant DNA Methylation and Prostate Cancer
Current Genomics Role of Microtubules Network in CYP Genes Expression
Current Drug Metabolism CYP24A1 as a Potential Target for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Prediction and Analysis of Hepatocellular Carcinoma Related Genes Using Gene Ontology and KEGG
Current Bioinformatics Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Current Genomics Carotenoids as Modulators of Intracellular Signaling Pathways
Current Signal Transduction Therapy E2F1-Mediated Apoptosis as a Target of Cancer Therapy
Current Molecular Pharmacology Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Current Drug Metabolism Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy
Mini-Reviews in Medicinal Chemistry Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design Advances in Molecular Therapeutic Approaches to Patients with Malignant Gliomas
Current Signal Transduction Therapy Discovery and Development of Purine-Scaffold Hsp90 Inhibitors
Current Topics in Medicinal Chemistry Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Signal Transduction in Human Cutaneous Melanoma and Target Drugs
Current Cancer Drug Targets Improved Immunotoxins with Novel Functional Elements
Current Pharmaceutical Design Clinical Applicability of Microarray Technology in the Diagnosis, Prognostic Stratification, Treatment and Clinical Surveillance of Cervical Adenocarcinoma
Current Pharmaceutical Design C. elegans as Model for Drug Discovery
Current Topics in Medicinal Chemistry